Cáncer renal subgrupos de pacientes y poblaciones especiales: ¿qué hemos aprendido? - page 80

Anti-programmed Cel l Death Protein 1 (PD-1) Antibody

Nivolumab Leads to a Dramatic and Rapid Response in Papillary

R l C ll C i

ith S t id d Rh bd id F t

ena e arc noma w arcoma o an a o ea ures

Geynisman DM. Eur Urol 2015;68:912‐5

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,70,71,72,73,74,75,76,77,78,79 81,82,83,84